Published in J Pharmacol Exp Ther on July 01, 1998
Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. J Biol Chem (2009) 1.59
The role of central mu opioid receptors in opioid-induced itch in primates. J Pharmacol Exp Ther (2004) 1.33
Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor. Proc Natl Acad Sci U S A (2013) 1.06
Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys. J Pharmacol Exp Ther (2003) 0.94
Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br J Pharmacol (1999) 0.93
Total synthesis and biological evaluation of phidianidines A and B uncovers unique pharmacological profiles at CNS targets. ACS Chem Neurosci (2012) 0.93
Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Br J Pharmacol (1999) 0.87
The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant mu-opioid receptors and SH-SY5Y cells. Br J Pharmacol (1999) 0.85
The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies. Anesth Analg (2008) 0.84
Nociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro. Br J Pharmacol (1999) 0.84
Differential A(1)-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cells. Br J Pharmacol (2000) 0.82
Endothelin-converting enzyme 2 differentially regulates opioid receptor activity. Br J Pharmacol (2014) 0.81
Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates. Psychoneuroendocrinology (2008) 0.81
Endomorphin 1 and endomorphin 2 suppress in vitro antibody formation at ultra-low concentrations: anti-peptide antibodies but not opioid antagonists block the activity. Brain Behav Immun (2008) 0.81
Stereochemical requirements for receptor recognition of the mu-opioid peptide endomorphin-1. Biophys J (2000) 0.80
Characterization of kappa opioid receptor mediated, dynorphin-stimulated [(35)S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting. Neuropharmacology (2015) 0.79
Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys. Eur J Pharmacol (2000) 0.78
Distinct functions of opioid-related peptides and gastrin-releasing peptide in regulating itch and pain in the spinal cord of primates. Sci Rep (2015) 0.78
Effects of withdrawal from chronic escalating-dose binge cocaine on conditioned place preference to cocaine and striatal preproenkephalin mRNA in C57BL/6J mice. Neuropharmacology (2012) 0.77
Contribution of Endogenous Spinal Endomorphin 2 to Intrathecal Opioid Antinociception in Rats Is Agonist Dependent and Sexually Dimorphic. J Pain (2015) 0.76
Ligand-specific regulation of the endogenous mu-opioid receptor by chronic treatment with mu-opioid peptide agonists. Biomed Res Int (2013) 0.76
Endomorphin-1 induced desensitization and down-regulation of the recombinant mu-opioid receptor. Br J Pharmacol (2000) 0.75
A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat Genet (2000) 3.71
Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci (1995) 3.00
Anatomy of CNS opioid receptors. Trends Neurosci (1988) 2.82
Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience (1995) 2.69
Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science (1991) 2.63
Endogenous opioids: biology and function. Annu Rev Neurosci (1984) 2.54
Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci (1987) 2.53
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci (2000) 2.42
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38
Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science (1976) 2.35
Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol (1994) 2.33
Controlling signaling with a specifically designed Gi-coupled receptor. Proc Natl Acad Sci U S A (1998) 2.22
Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A (2004) 2.19
Incorporation of endovascular training into a vascular fellowship program. Am J Surg (1995) 2.05
Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. Am J Psychiatry (1999) 1.94
Reaction routes in biochemical reaction systems: algebraic properties, validated calculation procedure and example from nucleotide metabolism. J Math Biol (2002) 1.81
Analgesia from electrical stimulation in the brainstem of the rat. Science (1971) 1.81
Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci (1999) 1.80
Concurrent performances: reinforcement by different doses of intravenous cocaine in rhesus monkeys. J Exp Anal Behav (1974) 1.78
Postoperative ileus: a colonic problem? Surgery (1978) 1.77
Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol (1999) 1.77
Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J Comp Neurol (1999) 1.76
Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry (1991) 1.75
Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron (1993) 1.68
A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Proc Natl Acad Sci U S A (1998) 1.67
Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacologia (1966) 1.63
Relative reinforcing effects of three opioids with different durations of action. J Pharmacol Exp Ther (2002) 1.63
Social stress in hamsters: defeat activates specific neurocircuits within the brain. J Neurosci (1997) 1.60
Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat (1995) 1.56
Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci (1990) 1.56
Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology (1997) 1.55
Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol (1999) 1.52
Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci (1989) 1.50
Differential binding properties of oripavines at cloned mu- and delta-opioid receptors. Eur J Pharmacol (1999) 1.48
Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology (Berl) (1994) 1.48
Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A (1993) 1.47
Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. J Pharmacol Exp Ther (2000) 1.47
The [35S]GTPgammaS binding assay: approaches and applications in pharmacology. Life Sci (2003) 1.47
Early progressive encephalopathy in boys and MECP2 mutations. Neurology (2006) 1.44
Familial Mediterranean fever in six Australian children. Med J Aust (1989) 1.43
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry (2010) 1.42
A food predictive cue must be attributed with incentive salience for it to induce c-fos mRNA expression in cortico-striatal-thalamic brain regions. Neuroscience (2011) 1.41
Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J Pharmacol Exp Ther (1996) 1.39
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Extrapulmonary tuberculosis in children. Med J Aust (1993) 1.38
Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol (1989) 1.38
Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat (1997) 1.37
Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther (1994) 1.36
Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav (2000) 1.34
mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res (1994) 1.34
Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop. Eur J Pharmacol (2000) 1.32
Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior. Psychopharmacology (Berl) (2001) 1.32
Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci (1998) 1.31
Differential expression of c-fos mRNA within neurocircuits of male hamsters exposed to acute or chronic defeat. J Neuroendocrinol (1999) 1.31
Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res (1999) 1.31
Pain reduction by electrical brain stimulation in man. Part 2: Chronic self-administration in the periventricular gray matter. J Neurosurg (1977) 1.30
Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res (1995) 1.29
Nonopiate effects of dynorphin and des-Tyr-dynorphin. Science (1982) 1.29
Immunocytochemical localization of methionine enkephalin: preliminary observations. Life Sci (1977) 1.28
Evidence for two separate opiate peptide neuronal systems. Nature (1978) 1.28
Effects of local anaesthetics on phospholipases. Biochim Biophys Acta (1976) 1.27
Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther (1993) 1.27
Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther (1987) 1.25
Inhibition of suppressor T-cell development following deoxyguanosine administration. Nature (1980) 1.24
The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res (1995) 1.24
Phenotypic and genotypic analysis of enterotoxigenic Escherichia coli in samples obtained from Egyptian children presenting to referral hospitals. J Clin Microbiol (2008) 1.24
Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys. J Pharmacol Exp Ther (1998) 1.24
Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis. J Neuroendocrinol (1995) 1.23
Neural circuits mediating stress. Biol Psychiatry (1999) 1.22
Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action. J Pharmacol Exp Ther (2002) 1.22
Dynorphin immunocytochemical localization in brain and peripheral nervous system: preliminary studies. Proc Natl Acad Sci U S A (1981) 1.19
Localization of the 90-kDa heat shock protein-binding site within the hormone-binding domain of the glucocorticoid receptor by peptide competition. J Biol Chem (1991) 1.19
Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry (2007) 1.18
Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract. Neuroscience (1997) 1.18
Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J Pharmacol Exp Ther (1993) 1.17
Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. J Pharmacol Exp Ther (1994) 1.17
Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A (1989) 1.17
Detection of proopiomelanocortin mRNA by in situ hybridization with an oligonucleotide probe. Proc Natl Acad Sci U S A (1986) 1.16
Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry (1994) 1.16
Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. J Pharmacol Exp Ther (1993) 1.15
Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Mol Cell Neurosci (1994) 1.15
Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine. J Pharmacol Exp Ther (2000) 1.14
Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin. Br J Psychiatry (1991) 1.14
Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci (2001) 1.13